COVID-19 vaccination in patients with α1-antitrypsin deficiency (AATD)

This comment discusses hypothetical reasons why individuals with AATD might derive limited benefit from the current COVID-19 vaccines and advocates that people with AATD be encouraged to adopt protective behaviours (e.g. lifestyle changes) in addition to COVID-19 vaccine uptake.

Source:

The Lancet Respiratory Medicine